Yiling Pharmaceuticals has paid $15m for a 23% stake in HealthWatch and another $5m for the Chinese distribution rights to its health-monitoring garment.
China-listed drug producer Yiling Pharmaceuticals has agreed to invest $20m in Israel-based smart clothing technology developer HealthWatch as part of a distribution deal.
HealthWatch has created a wearable garment it claims is capable of monitoring life signs including electrocardiography to a greater degree of accuracy than any previously achieved outside of a hospital environment.
The machine-washable clothing, which works through textile-sensing technology developed by HealthWatch, processes and sends the wearer’s medical data to a mobile device or to a medical…
